StockMacro
Menu

Pulmonx

$2.57 +64% in 6 monthsMarket cap $111.9M

LUNG on XNAS, Health Care, Pulmonx Corporation, job postings

Measures activity, not value. Not investment advice.

Shares rose 96% in a year while quarterly revenue grew 6.2% to $22.8M.

  • BadTwelve-month revenue fell 3.2% to $88.8M
  • BadNet loss of $42.6M over twelve months, free cash flow -$25.6M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
296
Website
pulmonx.com
Listed
Nasdaq, US
Last results
27 Oct 2026
Next results
expected around 3 Mar 2027 (an estimate: a year ago it reported on 4 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $22.8M, net loss $8.4M.
Quarter to 31 Dec 2021: revenue $13.7M, net income -$13.0MQuarter to 31 Dec 2021: revenue $13.7M, net income -$13.0MQuarter to 31 Mar 2022: revenue $10.8M, net income -$15.8MQuarter to 31 Mar 2022: revenue $10.8M, net income -$15.8MQuarter to 30 Jun 2022: revenue $13.9M, net income -$14.6MQuarter to 30 Jun 2022: revenue $13.9M, net income -$14.6MQuarter to 30 Sep 2022: revenue $13.5M, net income -$14.2MQuarter to 30 Sep 2022: revenue $13.5M, net income -$14.2MQuarter to 31 Dec 2022: revenue $15.4M, net income -$14.3MQuarter to 31 Dec 2022: revenue $15.4M, net income -$14.3MQuarter to 31 Mar 2023: revenue $14.5M, net income -$15.9MQuarter to 31 Mar 2023: revenue $14.5M, net income -$15.9MQuarter to 30 Jun 2023: revenue $17.2M, net income -$16.2MQuarter to 30 Jun 2023: revenue $17.2M, net income -$16.2MQuarter to 30 Sep 2023: revenue $17.7M, net income -$14.9MQuarter to 30 Sep 2023: revenue $17.7M, net income -$14.9MQuarter to 31 Dec 2023: revenue $19.3M, net income -$13.9MQuarter to 31 Dec 2023: revenue $19.3M, net income -$13.9MQuarter to 31 Mar 2024: revenue $18.9M, net income -$13.7MQuarter to 31 Mar 2024: revenue $18.9M, net income -$13.7MQuarter to 30 Jun 2024: revenue $20.8M, net income -$15.3MQuarter to 30 Jun 2024: revenue $20.8M, net income -$15.3MQuarter to 30 Sep 2024: revenue $20.4M, net income -$14.1MQuarter to 30 Sep 2024: revenue $20.4M, net income -$14.1MQuarter to 31 Dec 2024: revenue $23.8M, net income -$13.2MQuarter to 31 Dec 2024: revenue $23.8M, net income -$13.2MQuarter to 31 Mar 2025: revenue $22.5M, net income -$14.4MQuarter to 31 Mar 2025: revenue $22.5M, net income -$14.4MQuarter to 30 Jun 2025: revenue $23.9M, net income -$15.2MQuarter to 30 Jun 2025: revenue $23.9M, net income -$15.2MQuarter to 30 Sep 2025: revenue $21.5M, net income -$14.0MQuarter to 30 Sep 2025: revenue $21.5M, net income -$14.0MQuarter to 31 Dec 2025: revenue $22.6M, net income -$10.4MQuarter to 31 Dec 2025: revenue $22.6M, net income -$10.4MQuarter to 31 Mar 2026: revenue $20.6M, net income -$13.7MQuarter to 31 Mar 2026: revenue $20.6M, net income -$13.7MQuarter to 30 Jun 2026: revenue $22.8M, net income -$10.1MQuarter to 30 Jun 2026: revenue $22.8M, net income -$10.1MQuarter to 30 Sep 2026: revenue $22.8M, net income -$8.4MQuarter to 30 Sep 2026: revenue $22.8M, net income -$8.4M
31 Dec 2021RevenueNet incomeNet losstallest bar $23.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$22.8M-$8.4M
30 Jun 2026$22.8M-$10.1M
31 Mar 2026$20.6M-$13.7M
31 Dec 2025$22.6M-$10.4M
30 Sep 2025$21.5M-$14.0M
30 Jun 2025$23.9M-$15.2M
31 Mar 2025$22.5M-$14.4M
31 Dec 2024$23.8M-$13.2M
30 Sep 2024$20.4M-$14.1M
30 Jun 2024$20.8M-$15.3M
31 Mar 2024$18.9M-$13.7M
31 Dec 2023$19.3M-$13.9M
30 Sep 2023$17.7M-$14.9M
30 Jun 2023$17.2M-$16.2M
31 Mar 2023$14.5M-$15.9M
31 Dec 2022$15.4M-$14.3M
30 Sep 2022$13.5M-$14.2M
30 Jun 2022$13.9M-$14.6M
31 Mar 2022$10.8M-$15.8M
31 Dec 2021$13.7M-$13.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $88.8M $91.7M
Revenue growthRevenue of the last 12 months compared with the 12 months before. -3.2% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$42.6M -$56.8M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.01 -$1.41
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 77.4% 73.3% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -44.4% -62.4% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -47.9% -61.9% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -90.3% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$25.6M -$32.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $52.7M $76.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $37.9M $37.2M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$14.8M (net cash) -$39.3M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.1 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.79
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.3 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.1 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.3 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
PulmonxLUNG (this company) $111.9Mloss1.3-3.2%-47.9%
NeuroneticsSTIM $120.6Mloss0.61+23%-14.4%
Apyx MedicalAPYX $101.1Mloss1.7+24%-14.2%
KORU Medical SystemsKRMD $138.4Mloss3.0+18%-1.8%
TriSalus Life SciencesTLSI $143.1Mloss3.1+15%-56.6%
SkinHealth SystemsSKIN $76.7Mloss0.27-4.4%-6.3%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$177K

bought $0, sold $177K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-4.8%

100 13F filers vs 105

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

59%

25.5M shares held by 13F filers (30 Sep 2026) of 43.6M outstanding (29 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

1.8%

788K shares sold short (30 Oct 2026) of 43.6M outstanding (29 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.0

788K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+13%

699K shares sold short in the report before, 788K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

32%

32% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 44%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+6.2%

$22.8M vs $21.5M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$106K

the 12 months before: $455K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

7

7 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

7 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $2.57 on 20 Nov 2026, +96% over 12 months (12-month range $1.17 to $3.17)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $548K in the last 12 months (the 12 months before: -$1.3M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months.
Revenue per quarter. Revenue $22.8M in the latest quarter, +6.2% on a year earlier.
Capital spending per quarter. Capital spending $8K in the latest quarter, -91% on a year earlier.
Institutional holders (13F filers). 100 13F filers reported holding it in the latest 13F quarter, +1.0% on a year earlier.
Federal obligations. Federal obligations: $32K published in the last 12 months, -90% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
31 Mar 2026Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.5M (2026-03-13); 2.8x the same period a year earlier
17 Mar 2026Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.5M (2026-02-27); 2.6x the same period a year earlier
5 Mar 20268-K and other filingsA major agreement ended
3 Mar 2026Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.4M (2026-02-13); 2.9x the same period a year earlier
17 Feb 2026Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.4M (2026-01-30); 2.3x the same period a year earlier
3 Feb 2026Sharp changeShort interest spike: short interest spike, 2.6M vs usual 1.4M (2026-01-15); 2.1x the same period a year earlier
13 Jan 2026Sharp changeShort interest spike: short interest spike, 3.0M vs usual 1.4M (2025-12-31); 3.4x the same period a year earlier
30 Dec 2025Sharp changeShort interest spike: short interest spike, 3.1M vs usual 1.4M (2025-12-15); 3.7x the same period a year earlier
16 Dec 2025Sharp changeShort interest spike: short interest spike, 2.5M vs usual 1.3M (2025-11-28); 3.1x the same period a year earlier
2 Dec 2025Sharp changeShort interest spike: short interest spike, 2.0M vs usual 1.3M (2025-11-14); 2.4x the same period a year earlier
18 Nov 2025Sharp changeShort interest spike: short interest spike, 2.4M vs usual 1.3M (2025-10-31); 2.4x the same period a year earlier
27 Oct 20258-K and other filingsDirector or officer change
27 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Apr 20248-K and other filingsDirector or officer change
21 Feb 20248-K and other filingsDirector or officer change
21 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 Oct 20238-K and other filingsDirector or officer change
10 Oct 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Mar 2022Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.3M (2022-03-15); 2.4x the same period a year earlier
15 Mar 2022Sharp changeShort interest spike: short interest spike, 2.9M vs usual 1.2M (2022-02-28); 3.0x the same period a year earlier
1 Mar 2022Sharp changeShort interest spike: short interest spike, 2.6M vs usual 1.2M (2022-02-15); 2.8x the same period a year earlier
15 Feb 2022Sharp changeShort interest spike: short interest spike, 2.4M vs usual 1.2M (2022-01-31); 1.8x the same period a year earlier
Insider net buying (open market)
Month from 1 Nov 2021: -$899K published
Month from 1 Dec 2021: -$1.7M published
Month from 1 Jan 2022: -$628K published
Month from 1 Feb 2022: -$677K published
Month from 1 Mar 2022: -$64K published
Month from 1 Jun 2022: -$102K published
Month from 1 Aug 2022: -$1.0M published
Month from 1 Sep 2022: -$610K published
Month from 1 Nov 2022: $29K published
Month from 1 Dec 2022: -$31K published
Month from 1 Mar 2023: -$73K published
Month from 1 Jun 2023: -$326K published
Month from 1 Jul 2023: -$190K published
Month from 1 Aug 2023: -$12K published
Month from 1 Sep 2023: -$186K published
Month from 1 Oct 2023: -$10K published
Month from 1 Nov 2023: -$13K published
Month from 1 Dec 2023: -$287K published
Month from 1 Jan 2024: -$143K published
Month from 1 Feb 2024: -$309K published
Month from 1 Mar 2024: -$151K published
Month from 1 Apr 2024: -$9K published
Month from 1 May 2024: -$10K published
Month from 1 Jun 2024: -$75K published
Month from 1 Aug 2024: $97K published
Month from 1 Sep 2024: -$231K published
Month from 1 Oct 2024: -$130K published
Month from 1 Nov 2024: -$133K published
Month from 1 Dec 2024: -$61K published
Month from 1 Jan 2025: -$30K published
Month from 1 Feb 2025: -$459K published
Month from 1 Mar 2025: -$669K published
Month from 1 Jun 2025: -$65K published
Month from 1 Sep 2025: -$54K published
Month from 1 Dec 2025: -$86K published
Month from 1 Mar 2026: -$141K published
Month from 1 Jun 2026: -$144K published
Month from 1 Sep 2026: -$177K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 1 published
Quarter from 1 Jul 2022: 1 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Jul 2024: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $13.7M, +39% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $10.8M, +17% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $13.9M, +14% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $13.5M, +1.8% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $15.4M, +13% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $14.5M, +35% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $17.2M, +23% on a year earlier; public on 5 Aug 2023
Quarter ended 30 Sep 2023: $17.7M, +31% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Dec 2023: $19.3M, +25% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $18.9M, +30% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $20.8M, +21% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $20.4M, +15% on a year earlier; public on 2 Nov 2024
Quarter ended 31 Dec 2024: $23.8M, +23% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $22.5M, +20% on a year earlier; public on 3 May 2025
Quarter ended 30 Jun 2025: $23.9M, +15% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $21.5M, +5.5% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $22.6M, -4.9% on a year earlier; public on 11 Mar 2026
Quarter ended 31 Mar 2026: $20.6M, -8.7% on a year earlier; public on 5 May 2026
Quarter ended 30 Jun 2026: $22.8M, -4.6% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $22.8M, +6.2% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $1.1M; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $564K, +133% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $299K, -55% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $279K, -83% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $176K, -85% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $61K, -89% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $54K, -82% on a year earlier; public on 5 Aug 2023
Quarter ended 31 Dec 2023: $200K, +14% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $451K, +639% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $469K, +769% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $416K; public on 2 Nov 2024
Quarter ended 31 Dec 2024: $111K, -44% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $301K, -33% on a year earlier; public on 3 May 2025
Quarter ended 30 Jun 2025: $49K, -90% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $89K, -79% on a year earlier; public on 13 Nov 2025
Quarter ended 31 Dec 2025: $13K, -88% on a year earlier; public on 11 Mar 2026
Quarter ended 31 Mar 2026: $9K, -97% on a year earlier; public on 5 May 2026
Quarter ended 30 Jun 2026: $1K, -98% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $8K, -91% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 103; public on 14 Feb 2022
31 Mar 2022 report: 104; public on 16 May 2022
30 Jun 2022 report: 101; public on 15 Aug 2022
30 Sep 2022 report: 98; public on 14 Nov 2022
31 Dec 2022 report: 108; public on 14 Feb 2023
31 Mar 2023 report: 97; public on 15 May 2023
30 Jun 2023 report: 107; public on 14 Aug 2023
30 Sep 2023 report: 108; public on 14 Nov 2023
31 Dec 2023 report: 117; public on 14 Feb 2024
31 Mar 2024 report: 115; public on 15 May 2024
30 Jun 2024 report: 102; public on 14 Aug 2024
30 Sep 2024 report: 109; public on 14 Nov 2024
31 Dec 2024 report: 118; public on 14 Feb 2025
31 Mar 2025 report: 113; public on 15 May 2025
30 Jun 2025 report: 111; public on 14 Aug 2025
30 Sep 2025 report: 99; public on 14 Nov 2025
31 Dec 2025 report: 107; public on 17 Feb 2026
31 Mar 2026 report: 110; public on 15 May 2026
30 Jun 2026 report: 105; public on 14 Aug 2026
30 Sep 2026 report: 100; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $34K published
Month from 1 Mar 2022: $11K published
Month from 1 Apr 2022: $29K published
Month from 1 Jul 2022: $11K published
Month from 1 Aug 2022: $43K published
Month from 1 Sep 2022: $45K published
Month from 1 Oct 2022: $11K published
Month from 1 Nov 2022: $167K published
Month from 1 Jan 2023: $25K published
Month from 1 Feb 2023: $12K published
Month from 1 Apr 2023: $15K published
Month from 1 May 2023: $66K published
Month from 1 Jun 2023: $19K published
Month from 1 Jul 2023: $44K published
Month from 1 Aug 2023: $65K published
Month from 1 Sep 2023: $98K published
Month from 1 Oct 2023: $56K published
Month from 1 Nov 2023: $27K published
Month from 1 Dec 2023: $28K published
Month from 1 Feb 2024: $34K published
Month from 1 Mar 2024: -$34.7 published
Month from 1 May 2024: $44K published
Month from 1 Jun 2024: $36K published
Month from 1 Jul 2024: $46K published
Month from 1 Aug 2024: $103K published
Month from 1 Sep 2024: $37K published
Month from 1 Oct 2024: $86K published
Month from 1 Nov 2024: $22K published
Month from 1 Dec 2024: $53K published
Month from 1 Jan 2025: $15K published
Month from 1 Feb 2025: $12K published
Month from 1 Mar 2025: $93K published
Month from 1 Apr 2025: $12K published
Month from 1 May 2025: $96.1 published
Month from 1 Jun 2025: $34K published
Month from 1 Jul 2025: $12K published
Month from 1 Aug 2025: $27K published
Month from 1 Sep 2025: $10K published
Month from 1 Oct 2025: $20K published
Month from 1 Nov 2025: $19K published
Month from 1 Jul 2026: $29K published
Month from 1 Oct 2026: $3K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $177K (3 Sep 2026), 2.1× its normal reading; higher than 60% of its own history.
  • Insider net buying (open market): Insiders sold a net $548K in the last 12 months (the 12 months before: -$1.3M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 0 published in the last 12 months.
  • Revenue per quarter: Revenue $22.8M in the latest quarter, +6.2% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 4 sales, $177K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
3 Sep 2026Geoffrey Beran RoseChief Commercial OfficerSell7,879$2.26$18KForm 4
3 Sep 2026Glendon E. French IIIPresident and CEOSell41,882$2.26$95KForm 4
3 Sep 2026David Aaron LehmanGeneral CounselSell14,334$2.26$32KForm 4
3 Sep 2026Srikanth RadhakrishnanChief Science & Techn. OfficerSell14,245$2.26$32KForm 4
3 Jun 2026David Aaron LehmanGENERAL COUNSELSell14,594$1.54$22KForm 4
3 Jun 2026Srikanth RadhakrishnanChief Science &Techn. OfficerSell14,497$1.54$22KForm 4
3 Jun 2026Glendon E. French IIIPresident and CEOSell56,149$1.55$87KForm 4
3 Jun 2026Geoffrey Beran RoseCHIEF COMMERCIAL OFFICERSell8,023$1.54$12KForm 4

100 institutions reported shares at the end of Q3 2026, 59% of the shares outstanding; 15 opened a position, 19 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Primecap Management Co4.4M10.1%$8.4M-204K-4.4%
Morgan Stanley3.3M7.48%$6.2M+333K+11%
Soleus Capital Management, L.P.3.1M7.09%$5.9M+300K+11%
Vanguard Capital Management LLC1.7M3.90%$3.2M+67K+4.1%
ExodusPoint Capital Management, LP1.3M3.02%$2.5M+90K+7.4%
Almitas Capital LLC1.1M2.48%$2.1M+16K+1.5%
Parkman Healthcare Partners LLC854K1.96%$1.6M+207K+32%
BlackRock, Inc.766K1.76%$1.5M-117K-13%
Braidwell LP753K1.73%$1.4MNo change
D. E. Shaw & Co., Inc.741K1.70%$1.4M+413K+126%

Company events

All 17 company events

In 12 months: 1 major agreement, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
4 Mar 2026Signed a major agreement; A major agreement endedSame filing: took on new debt, sold shares privately8-K
27 Oct 2025Director or officer change8-K
23 May 2024Signed a major agreement8-K
2 Apr 2024Director or officer change8-K
21 Feb 2024Director or officer change8-K
10 Oct 2023Director or officer change8-K
3 Nov 2022Signed a major agreement8-K
2 Aug 2021Director or officer change8-K

The 5 newest of 30 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 25 Mar 2026Short interest and volume change

    had 3.3M shares sold short in the 13 Mar 2026 report, 2.8× the same report last year.

    Same report last year: 1.2M; its normal report is 1.5M.

    See the evidence
    This period
    3.3M (the 13 Mar 2026 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    333K
    How far from its usual level
    +3.5
    Same report last year
    1.2M
    History used
    1,975 days
    2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M2025-11-28: 2.5M2025-12-15: 3.1M2025-12-31: 3.0M2026-01-15: 2.6M2026-01-30: 2.8M2026-02-13: 3.3M2026-02-27: 3.3M2026-03-13: 3.3M
    the 13 Mar 2026 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 11 Mar 2026Short interest and volume change

    had 3.3M shares sold short in the 27 Feb 2026 report, 2.6× the same report last year.

    Same report last year: 1.3M; its normal report is 1.5M.

    See the evidence
    This period
    3.3M (the 27 Feb 2026 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    273K
    How far from its usual level
    +4.5
    Same report last year
    1.3M
    History used
    1,961 days
    2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M2025-11-28: 2.5M2025-12-15: 3.1M2025-12-31: 3.0M2026-01-15: 2.6M2026-01-30: 2.8M2026-02-13: 3.3M2026-02-27: 3.3M
    the 27 Feb 2026 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 5 Mar 2026Filings record

    A major agreement ended (dated 4 Mar 2026)

  4. 26 Feb 2026Short interest and volume change

    had 3.3M shares sold short in the 13 Feb 2026 report, 2.9× the same report last year.

    Same report last year: 1.1M; its normal report is 1.4M.

    See the evidence
    This period
    3.3M (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    226K
    How far from its usual level
    +5.5
    Same report last year
    1.1M
    History used
    1,947 days
    2025-02-14: 1.1M2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M2025-11-28: 2.5M2025-12-15: 3.1M2025-12-31: 3.0M2026-01-15: 2.6M2026-01-30: 2.8M2026-02-13: 3.3M
    the 13 Feb 2026 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Feb 2026Short interest and volume change

    had 2.8M shares sold short in the 30 Jan 2026 report, 2.3× the same report last year.

    Same report last year: 1.2M; its normal report is 1.4M.

    See the evidence
    This period
    2.8M (the 30 Jan 2026 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    213K
    How far from its usual level
    +4.4
    Same report last year
    1.2M
    History used
    1,933 days
    2025-01-31: 1.2M2025-02-14: 1.1M2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M2025-11-28: 2.5M2025-12-15: 3.1M2025-12-31: 3.0M2026-01-15: 2.6M2026-01-30: 2.8M
    the 30 Jan 2026 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 28 Jan 2026Short interest and volume change

    had 2.6M shares sold short in the 15 Jan 2026 report, 2.1× the same report last year.

    Same report last year: 1.3M; its normal report is 1.4M.

    See the evidence
    This period
    2.6M (the 15 Jan 2026 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    191K
    How far from its usual level
    +4.3
    Same report last year
    1.3M
    History used
    1,918 days
    2025-01-15: 1.3M2025-01-31: 1.2M2025-02-14: 1.1M2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M2025-11-28: 2.5M2025-12-15: 3.1M2025-12-31: 3.0M2026-01-15: 2.6M
    the 15 Jan 2026 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 13 Jan 2026Short interest and volume change

    had 3.0M shares sold short in the 31 Dec 2025 report, 3.4× the same report last year.

    Same report last year: 879K; its normal report is 1.4M.

    See the evidence
    This period
    3.0M (the 31 Dec 2025 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    169K
    How far from its usual level
    +6.3
    Same report last year
    879K
    History used
    1,903 days
    2024-12-31: 879K2025-01-15: 1.3M2025-01-31: 1.2M2025-02-14: 1.1M2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M2025-11-28: 2.5M2025-12-15: 3.1M2025-12-31: 3.0M
    the 31 Dec 2025 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 25 Dec 2025Short interest and volume change

    had 3.1M shares sold short in the 15 Dec 2025 report, 3.7× the same report last year.

    Same report last year: 832K; its normal report is 1.4M.

    See the evidence
    This period
    3.1M (the 15 Dec 2025 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    169K
    How far from its usual level
    +6.9
    Same report last year
    832K
    History used
    1,887 days
    2024-12-13: 832K2024-12-31: 879K2025-01-15: 1.3M2025-01-31: 1.2M2025-02-14: 1.1M2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M2025-11-28: 2.5M2025-12-15: 3.1M
    the 15 Dec 2025 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 10 Dec 2025Short interest and volume change

    had 2.5M shares sold short in the 28 Nov 2025 report, 3.1× the same report last year.

    Same report last year: 816K; its normal report is 1.3M.

    See the evidence
    This period
    2.5M (the 28 Nov 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    145K
    How far from its usual level
    +5.6
    Same report last year
    816K
    History used
    1,870 days
    2024-11-29: 816K2024-12-13: 832K2024-12-31: 879K2025-01-15: 1.3M2025-01-31: 1.2M2025-02-14: 1.1M2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M2025-11-28: 2.5M
    the 28 Nov 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 26 Nov 2025Short interest and volume change

    had 2.0M shares sold short in the 14 Nov 2025 report, 2.4× the same report last year.

    Same report last year: 843K; its normal report is 1.3M.

    See the evidence
    This period
    2.0M (the 14 Nov 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    135K
    How far from its usual level
    +3.8
    Same report last year
    843K
    History used
    1,856 days
    2024-11-15: 843K2024-11-29: 816K2024-12-13: 832K2024-12-31: 879K2025-01-15: 1.3M2025-01-31: 1.2M2025-02-14: 1.1M2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M2025-11-14: 2.0M
    the 14 Nov 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 13 Nov 2025Short interest and volume change

    had 2.4M shares sold short in the 31 Oct 2025 report, 2.4× the same report last year.

    Same report last year: 986K; its normal report is 1.3M.

    See the evidence
    This period
    2.4M (the 31 Oct 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    165K
    How far from its usual level
    +4.5
    Same report last year
    986K
    History used
    1,842 days
    2024-10-31: 986K2024-11-15: 843K2024-11-29: 816K2024-12-13: 832K2024-12-31: 879K2025-01-15: 1.3M2025-01-31: 1.2M2025-02-14: 1.1M2025-02-28: 1.3M2025-03-14: 1.2M2025-03-31: 1.2M2025-04-15: 1.2M2025-04-30: 1.2M2025-05-15: 1.6M2025-05-30: 1.3M2025-06-13: 1.4M2025-06-30: 1.3M2025-07-15: 1.4M2025-07-31: 1.4M2025-08-15: 1.5M2025-08-29: 1.6M2025-09-15: 1.8M2025-09-30: 1.4M2025-10-15: 1.4M2025-10-31: 2.4M
    the 31 Oct 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 27 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 27 Oct 2025Filings record

    Director or officer change

  14. 6 Jun 2025Insiders record

    Florin Daniel P (director) bought 23,321 shares of LUNG ($71,362) (dated 5 Jun 2025)

  15. 23 Aug 2024Insiders record

    Williamson Steven S. (PRESIDENT AND CEO) bought 14,245 shares of LUNG ($97,436) (dated 22 Aug 2024)

  16. 2 Apr 2024Filings record

    Director or officer change

  17. 21 Feb 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 21 Feb 2024Filings record

    Director or officer change

  19. 10 Oct 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 10 Oct 2023Filings record

    Director or officer change

  21. 2 Dec 2022Insiders record

    Lynch Alissa Hsu (director) bought 1,700 shares of LUNG ($9,367) (dated 1 Dec 2022)

  22. 11 Nov 2022Insiders record

    Ferrari Richard (director) bought 5,438 shares of LUNG ($28,874) (dated 10 Nov 2022)

  23. 25 Mar 2022Short interest and volume change

    had 2.8M shares sold short in the 15 Mar 2022 report, 2.4× the same report last year.

    Same report last year: 1.1M; its normal report is 1.3M.

    See the evidence
    This period
    2.8M (the 15 Mar 2022 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    288K
    How far from its usual level
    +3.6
    Same report last year
    1.1M
    History used
    516 days
    2021-02-26: 969K2021-03-15: 1.1M2021-03-31: 2.0M2021-04-15: 852K2021-04-30: 799K2021-05-14: 1.0M2021-05-28: 958K2021-06-15: 968K2021-06-30: 1.2M2021-07-15: 1.1M2021-07-30: 1.1M2021-08-13: 1.2M2021-08-31: 1.3M2021-09-15: 1.2M2021-09-30: 1.4M2021-10-15: 1.4M2021-10-29: 1.5M2021-11-15: 1.5M2021-11-30: 1.7M2021-12-15: 2.0M2022-01-14: 1.7M2022-01-31: 2.4M2022-02-15: 2.6M2022-02-28: 2.9M2022-03-15: 2.8M
    the 15 Mar 2022 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 10 Mar 2022Short interest and volume change

    had 2.9M shares sold short in the 28 Feb 2022 report, 3.0× the same report last year.

    Same report last year: 969K; its normal report is 1.2M.

    See the evidence
    This period
    2.9M (the 28 Feb 2022 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    247K
    How far from its usual level
    +4.7
    Same report last year
    969K
    History used
    501 days
    2021-02-12: 922K2021-02-26: 969K2021-03-15: 1.1M2021-03-31: 2.0M2021-04-15: 852K2021-04-30: 799K2021-05-14: 1.0M2021-05-28: 958K2021-06-15: 968K2021-06-30: 1.2M2021-07-15: 1.1M2021-07-30: 1.1M2021-08-13: 1.2M2021-08-31: 1.3M2021-09-15: 1.2M2021-09-30: 1.4M2021-10-15: 1.4M2021-10-29: 1.5M2021-11-15: 1.5M2021-11-30: 1.7M2021-12-15: 2.0M2022-01-14: 1.7M2022-01-31: 2.4M2022-02-15: 2.6M2022-02-28: 2.9M
    the 28 Feb 2022 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 26 Feb 2022Short interest and volume change

    had 2.6M shares sold short in the 15 Feb 2022 report, 2.8× the same report last year.

    Same report last year: 922K; its normal report is 1.2M.

    See the evidence
    This period
    2.6M (the 15 Feb 2022 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    241K
    How far from its usual level
    +3.9
    Same report last year
    922K
    History used
    488 days
    2021-01-29: 1.4M2021-02-12: 922K2021-02-26: 969K2021-03-15: 1.1M2021-03-31: 2.0M2021-04-15: 852K2021-04-30: 799K2021-05-14: 1.0M2021-05-28: 958K2021-06-15: 968K2021-06-30: 1.2M2021-07-15: 1.1M2021-07-30: 1.1M2021-08-13: 1.2M2021-08-31: 1.3M2021-09-15: 1.2M2021-09-30: 1.4M2021-10-15: 1.4M2021-10-29: 1.5M2021-11-15: 1.5M2021-11-30: 1.7M2021-12-15: 2.0M2022-01-14: 1.7M2022-01-31: 2.4M2022-02-15: 2.6M
    the 15 Feb 2022 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 10 Feb 2022Short interest and volume change

    had 2.4M shares sold short in the 31 Jan 2022 report, 1.8× the same report last year.

    Same report last year: 1.4M; its normal report is 1.2M.

    See the evidence
    This period
    2.4M (the 31 Jan 2022 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    237K
    How far from its usual level
    +3.5
    Same report last year
    1.4M
    History used
    473 days
    2021-01-15: 1.4M2021-01-29: 1.4M2021-02-12: 922K2021-02-26: 969K2021-03-15: 1.1M2021-03-31: 2.0M2021-04-15: 852K2021-04-30: 799K2021-05-14: 1.0M2021-05-28: 958K2021-06-15: 968K2021-06-30: 1.2M2021-07-15: 1.1M2021-07-30: 1.1M2021-08-13: 1.2M2021-08-31: 1.3M2021-09-15: 1.2M2021-09-30: 1.4M2021-10-15: 1.4M2021-10-29: 1.5M2021-11-15: 1.5M2021-11-30: 1.7M2021-12-15: 2.0M2022-01-14: 1.7M2022-01-31: 2.4M
    the 31 Jan 2022 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 2 Aug 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 2 Aug 2021Filings record

    Director or officer change

  29. 14 Jul 2021Insiders record

    Florin Daniel P (director) bought 2,500 shares of LUNG ($100,000) (dated 13 Jul 2021)

  30. 29 Jun 2021Insiders record

    Florin Daniel P (director) bought 2,222 shares of LUNG ($98,035) (dated 28 Jun 2021)

  31. 24 Mar 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 24 Mar 2021Filings record

    Director or officer change

  33. 6 Oct 2020Insiders change

    had 3 insiders buy $1.0M of its shares on the open market within 30 days (3 filings).

    Who bought: Florin Daniel P, Ferrari Richard M, Mead Dana G Jr..

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $1.0M
    Window
    6 Sep 2020 to 6 Oct 2020

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  34. 6 Oct 2020Insiders record

    Mead Dana G Jr. (director) bought 26,315 shares of LUNG ($499,985) (dated 5 Oct 2020)

  35. 6 Oct 2020Insiders record

    FERRARI RICHARD M (director) bought 13,157 shares of LUNG ($249,983) (dated 5 Oct 2020)

  36. 6 Oct 2020Insiders record

    Melenikiotou Georgia (director) bought 26,315 shares of LUNG [same transaction as an earlier filing] (dated 5 Oct 2020)

  37. 6 Oct 2020Insiders record

    Florin Daniel P (director) bought 15,789 shares of LUNG ($299,991) (dated 5 Oct 2020)

  38. 30 Sep 2020Filings record

    Registered new securities for sale (S-1)

  39. 28 Sep 2020Filings record

    Registered new securities for sale (S-1)

  40. 24 Sep 2020Filings record

    Registered new securities for sale (S-1)

Showing the newest 40 of 44 entries; narrow the window or the kind of data to see older ones.

Not listed: 190 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001127537
Ticker
LUNG
Domain
pulmonx.com
Employer name
Pulmonx, Inc (1 unverified)
Hq location
CA|REDWOOD CITY|94063 (1 unverified)
Name
Pulmonx Corporation
Uei
FNLDP73STNA9
  • DOL H-1B labor condition applications and PERM certifications26 data points28 Oct 2019 to 8 Apr 2024
  • SEC Form 13F institutional holdings216 data points31 Dec 2020 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)71 records3 Apr 2017 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)575 data points31 Dec 2017 to 29 Oct 2026
  • SEC Form 4 insider transactions143 records, 312 data points5 Oct 2020 to 3 Sep 2026
  • FINRA short interest (twice monthly)434 data points15 Oct 2020 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3086 data points1 Oct 2020 to 20 Nov 2026
  • USASpending.gov federal awards285 data points9 Sep 2020 to 28 Sep 2026